H.C. Wainwright Downgrades Principia Biopharma (PRNB) to Neutral
Tweet
Share
E-mailGet Alerts PRNB Hot Sheet
Price: $100.05 --0%
Rating Summary:
4 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 4 | New: 4
Rating Summary:
4 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 4 | New: 4
Join SI Premium – FREE
H.C. Wainwright analyst Joseph Pantginis downgraded Principia Biopharma (NASDAQ: PRNB) from Buy to Neutral with a price target of $100.00 (from $108.00).
For an analyst ratings summary and ratings history on Principia Biopharma click here. For more ratings news on Principia Biopharma click here.
Shares of Principia Biopharma closed at $99.25 yesterday.
You May Also Be Interested In
- Deutsche Bank Downgrades Shurgard Self Storage SA (SHUR:BB) to Hold
- Isuzu Motors Limited (7202:JP) (ISUZY) PT Lowered to JPY2,400 at Citi
- UBS Downgrades Core Natural Resources (CNR) to Neutral
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
